|
||
Brief Definitive Report |
CORRESPONDENCE Shuh Narumiya: snaru{at}mfour.med.kyoto-u.ac.jp
|
|
|---|
Cell migration plays a critical role in various processes of acquired immunity, such as egression of naive T cells from the thymus and their homing to secondary lymphoid organs (1). Such trafficking of immune cells is controlled by their directed migration toward chemotactic signals. Actin cytoskeleton undergoes continuous remodeling and serves as machinery for cell migration (2). A critical step in this remodeling is formation of actin oligomers that serve as nuclei for further polymerization. The actin nucleation and polymerization can occur spontaneously but are facilitated by the catalysis by groups of proteins. The mDia family of formins and the Wiskott-Aldrich syndrome protein (WASP)–Arp2/3 system are two major actin nucleating–polymerizing systems in mammalian cells, with the former producing long straight actin filaments and the latter producing branched actin meshwork (3–5). The WASP–Arp2/3 system is under regulation by Cdc42 and Rac, two members of the Rho family of small GTPases, and actin meshworks induced by the WASP–Arp2/3 complex serve as an underlying structure for lammellipodia and filopodia, the structures that are induced by Rac and Cdc42, respectively (6), and promote directed cell migration (2, 5). The role of the WASP–Arp2/3 system in cell migration has been verified by the phenotypes of WAS patients with mutations in WASP and WASP-deficient mice, which showed defects in proliferation, differentiation, and migration of cells of the hematopoietic lineage (7, 8). In contrast, the mDia proteins were originally identified as Rho effectors (9). Straight actin filaments induced by mDia proteins are therefore used, for example, for stress fiber assembly (10, 11), a process regulated by Rho (6), and in contrast to the WASP–Arp2/3 system, their function in cell migration remains obscure. Furthermore, because functions of the mDia proteins have been studied mainly in cultured cells (3), little is known about their physiological roles in vivo. To address these issues, we generated mice deficient in one of the mDia proteins, mDia1 (9).
![]()
RESULTS AND DISCUSSION
Top
ABSTRACT
RESULTS AND DISCUSSION
MATERIALS AND METHODS
REFERENCES
We generated an mDia1-floxed strain of mice that allows deletion of the translation initiation exon, Exon 1, of mDia1 on Cre/loxP-mediated recombination (Fig. S1, A and B, available at http://www.jem.org/cgi/content/full/jem.20062647/DC1). mDia1+/flox heterozygotes were then crossed with EIIa-Cre mice, in which Cre recombinase was expressed in the early embryo (12), to produce heterozygous mDia1+/– mice, which were intercrossed to produce homozygous mDia1–/– mice (Fig. S1 C). No expression of mDia1 protein was found in mDia1–/– mice, whereas expression of mDia2 and mDia3 proteins was not altered (Fig. 1 A).
mDia1–/– mice were born with an expected Mendelian ratio (Fig. S1 D). Both male and female mDia1–/– mice developed without apparent abnormality and were fertile. Generated mDia1–/– mice were backcrossed for more than five generations to a C57BL/6 background and used for analysis with wild-type littermates obtained from the same heterozygous mating as a control. 8–12-wk-old mice were used in subsequent analyses.
|
Given that trafficking of thymocytes and T cells is achieved by their migration to chemokines (1), we examined the response of these cells toward chemokines in vitro. The transwell assay revealed impaired chemotaxis of mDia1–/– T cells toward CXC chemokine ligand (CXCL) 12 and CC chemokine ligand (CCL) 21, the two chemokines implicated in in vivo trafficking to secondary lymphoid organs (13). On the other hand, no significant impairment was found in chemotaxis of mDia1–/– B cells toward CXCL12 (Fig. 2 A).
Similarly, the transwell assay revealed impaired chemotaxis of CD4+CD8+, CD4+CD8–, and CD4–CD8+ thymocytes toward CXCL12 (14) and CCL21 in the mDia1–/– genotype (Fig. 2 B). To assess egression more directly, we used organ culture of the thymus. Egression of CD4+CD8– and CD4–CD8+ thymocytes from thymic lobes in response to CCL21 was significantly decreased in mDia1 deficiency (Fig. 2 C). These results indicate that impaired chemotaxis of thymocytes and T cells underlies the phenotype observed in mDia1–/– mice. However, T cell trafficking to lymphoid organs in vivo may not be determined solely by the migratory activity of T cells but can be influenced by other factors, including the adhesive property of high endothelium venules in the lymphoid organs (15). To examine this issue, we performed an adoptive transfer experiment, in which we labeled T cells from wild-type and mDia1–/– mice with different fluorescent dyes and infused them i.v. into wild-type or mDia1–/– recipients. The numbers of transferred cells that migrated into the spleen and lymph nodes were determined 2 h after the infusion. We observed that, compared with wild-type cells, only
50% of mDia1–/– T cells migrated into the spleen and lymph nodes and that the extent of the reduction was not different in wild-type and mDia1–/– recipients (Fig. 2 D). Consistently, the higher numbers of mDia1–/– cells remained in the circulation.
|
|
|
25% of that in wild-type cells. In contrast to these findings, RT-PCR analysis revealed that similar amounts of WASP transcript were present in wild-type and mDia1–/– cells (Fig. S3, available at http://www.jem.org/cgi/content/full/jem.20062647/DC1). We therefore treated wild-type and mDia1–/– T cells with cycloheximide and compared the rate of disappearance of WASP in the two genotypes of cells by immunoblot analysis. We found that the amount of WASP decreased more quickly in mDia1–/– T cells than in wild-type cells with half-lives of
6 and 11 h, respectively (Fig. 5 C). To examine a mechanism for accelerated WASP degradation, we next examined the effects of a poteasome inhibitor, MG132. The addition of MG132 concentration dependently restored the amount of WASP in mDia1–/–T cells, which was doubled by incubation with 20 µM MG132 for 4 h. On the contrary, MG132 had no effect on WASP amounts in wild-type cells (Fig. 5 D). Thus, WASP appears to be degraded via a ubiquitin–proteasome pathway in the absence of mDia. Because WASP is one of the components of another major actin-nucleating–polymerizing system and is involved in the migration and proliferation of T cells, these findings raised a question as to whether the phenotype we observed is caused by the lack of mDia1 or partial depletion of WASP. To address this issue, we overexpressed WASP in wild-type and mDia1–/– T cells as an enhanced GFP (EGFP)–fusion protein to 17 and 19% of the level of endogenous WASP in wild-type and mDia1–/– T cells, respectively. We also expressed EGFP as a control. Transfection efficiency was
5% for EGFP-WASP and
13% for EGFP, indicating that EGFP-WASP was present in transfected mDia1–/– cells at the level of endogenous WASP in control cells. Cells expressing EGFP or EGFP-WASP were then subjected to the migration assay and F-actin staining. Overexpression of EGFP-WASP neither improved the migratory activity nor rescued impaired polarization and F-actin increase of mDia1–/– cells (Fig. 5 E). These results suggest that a defect in the migration of mDia1–/– T cells is primarily caused by the loss of mDia1 itself.
|
In this respect, it is intriguing that WASP is depleted in the absence of mDia1, because this finding indicates not only functional but also physical interdependency of the two major actin-nucleating systems in the cell. Our results indicate that the WASP depletion in mDia1–/– cells is caused by accelerated degradation via the ubiquitin–proteasome system. Previously, phosphorylation of neural WASP by the Src family kinases was found to render it susceptible to ubiquination and degradation (19). Furthermore, WAVE2, a WASP family protein, is stabilized by making a multiprotein complex, and depletion of any other component of that complex triggers WAVE2 degradation via the ubiquitin–proteasome system (20). These findings indicate that mDia1 might regulate phosphorylation or complex formation of WASP in cells. In this respect, it is interesting that mDia1 interacts with Src and regulates its targeting in the cell (16, 21), and that mDia1 physically binds to the WASP-interacting SH3 protein/mDia-interacting protein that can also bind to WASP (22, 23). mDia1 and WASP were originally thought to act separately to induce distinct classes of actin structure. However, recent findings suggest that they work more closely and may cooperatively induce filopodia and lammellipodia (3). Thus, future analysis of the findings obtained in the present report will unravel unforeseen interrelationships between the two actin-nucleating systems that not only function cooperatively but also regulate each other's stability in the cell.
Given that the mDia family of proteins play elemental roles in actin filament dynamics, it is rather surprising that mDia1–/– mice exhibited relatively mild phenotypes. This is partly because of the redundancy of the mDia isoforms (3), but may also be caused by the presence of other cell-migration machinery. The latter possibility is consistent with our results on B cells (Fig. 2 A). mDia1 is the major, almost sole, mDia isoform in B cells (unpublished data), and there is a negligible amount of WASP in B cells. Yet, there is no B cell phenotype in mDia1–/– mice, and mDia1–/– B cells responded normally to chemotactic stimuli. In summary, our present report has demonstrated an essential role of mDia1 in T lymphocyte trafficking. This work should lead to a better understanding of not only immune trafficking and its defects in humans but also of various pathological processes involving cell migration.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Cell sorting, chemotaxis, and proliferation.
Dissociated T cell and B cell suspensions were prepared from the spleen using an autoMACS system (Miltenyi Biotec) and were cultured as described previously (24). Chemotaxis was assayed using a transwell, as previously described (24). In brief, 3 x 105 T cells, B cells, or thymocytes were used, and cells that had migrated to the lower chamber after 3 h of incubation at 37°C were collected and counted by flow cytometry. For expression of EGFP-WASP, 2–4 µg of pEGFP-WASP were transfected into T cells from wild-type or mDia1–/– mice using the Nucleofector system (Amaxa) with an efficiency of
5% and incubated for 18 h at 37°C. The cells were subjected to Western blotting and chemotaxis assay. For thymocyte egression, a thymic lobe from new-born mice was transferred to the top chamber of a transwell, and 600 µl of the medium containing 100 nM CCL21 was added to the bottom chamber. After 24 h of incubation at 37°C, cells that had egressed from the lobe and migrated to the bottom chamber were collected and analyzed by flow cytometry. For T cell proliferation, T cells were isolated from the spleen of mDia1+/+ and mDia1–/– mice, and 2 x 105 cells were cultured for 48 h with plate-bound anti-CD3 antibody, or 2.5 x 105 cells were cultured with CD11c+ dendritic cells from BALB/c mice for 72 h. [3H]Thymidine uptake was measured as previously described (24).
Adoptive transfer.
T cells were isolated from the spleen of mDia1+/+ or mDia1–/– mice and were labeled differentially with either 2 µM PKH-26 red fluorescent cell linker (Sigma-Aldrich) or 1 µM 5,6-carboxyfluorescein diacetate (Invitrogen) (25). After washing, mDia1+/+ and mDia1–/– T cells were mixed in equal numbers in PBS, and 5 x 106 cells were i.v. injected into recipient C57BL/6 or mDia1–/– mice. After 2 h, the blood, spleen, and lymph nodes were removed from the recipient mice. A cell suspension was prepared, and the numbers of cells labeled with each dye were analyzed by flow cytometry.
Western blotting.
The brain, lung, and thymus were isolated from adult mice, and T cells were prepared from the spleen. These organs and cells were lysed in RIPA buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% Nonidet P-40, 1% Na deoxycholate, 0.1% SDS) containing a mixture of protease inhibitors (10 µg/ml aprotin, 10 µg/ml leupeptin, 1 mM PMSF) and 5 mM 2-mercaptoethanol. The lysates were boiled and subjected to SDS-PAGE, and separated proteins were transferred to nitrocellulose membranes. The membranes were probed with antibodies to mDia1 (Bethyl Laboratories), mDia3, RhoA, ROCK-1, WASP (Santa Cruz Biotechnology, Inc.), ROCK-2, Rac1, Cdc42 (Transduction Laboratories), Arp2/3 subunit 34 (Imgenex), β-actin (Sigma-Aldrich), GFP (MBL International Corporation), or mDia2. Antibody to mDia2 (provided by Y. Ando, Kyoto University Faculty of Medicine, Kyoto, Japan) was raised in rabbits against a recombinant protein corresponding to Rho-binding domain of mDia2 expressed in Escherichia coli as a His-tagged protein. To examine the stability of WASP, T cells were incubated with 10 µg/ml cycloheximide for 0, 1, 2, 4, 8, 12, and 16 h. The cells were subjected to Western blotting for WASP. The effects of MG132 were examined by incubating T cells with 0, 1, 5, and 20 µM MG-132 (Peptide Institute) for 4 h.
Fluorescence microscopy.
Cryostat sections were prepared from the spleen and lymph node, fixed in cold acetone for 10 min, and stained with FITC- or PE-labeled anti-Thy1.2 or anti-B220 monoclonal antibodies. For chemokine responses, cells were cultured in the culture medium at 37°C overnight on poly–L-lysine–coated coverslips, and the medium was changed with the fresh medium with or without 100 ng/ml CCL21 (R&D Systems) for T cells or 500 ng/ml CXCL13 (R&D Systems) for B cells. After 10 min, the cells were fixed with 4% paraformaldehyde in PBS, permeabilized with 0.1% Triton X-100, and stained with antibody to talin, Texas red–phalloidin, and TOPRO3. Talin was visualized by Alexa Fluor 488–labeled anti–mouse IgG monoclonal antibody. Samples were analyzed on a confocal laser scanning microscope (LSM510; Carl Zeiss MicroImaging, Inc.). Fluorescence intensity of F-actin staining with Texas red–phalloidin was determined in each cell by using MetaMorph (Universal Imaging Corp.), as previously described (16).
Flow cytometric analysis.
Cell suspensions were prepared from the thymus, spleen, and lymph node and were incubated with FITC- or PE-labeled monoclonal antibody to CD4, CD8, Thy1.2, B220, CD11c, CD11b, CD62L, CD69, CXCR4, or CCR7 (29). For analysis of the CD69lo CD62Lhi thymocyte subset, Cy5- or APC-labeled monoclonal antibody to CD4 or CD8 was used. Labeled cells were then subjected to flow cytometry. For analysis of F-actin production, 106 T cells were stimulated with CCL21 for various times and fixed with 4% paraformaldehyde in PBS, treated with 0.1% saponin, and stained with Oregon green–phalloidin (26).
Contact hypersensitivity.
Mice were immunized by application of 25 µl of 0.5% DNFB in 4:1 (vol/vol) acetone/olive oil to their shaved abdomens on day 0 and were challenged on day 5 by paining the ear with 20 µl of 0.3% (wt/vol) DNFB. Ear thickness was measured 24 h after challenge.
Statistical analysis.
All data are shown as means ± SEM. Comparisons of two groups were analyzed using the unpaired two-tailed Student's t test. P < 0.05 was considered statistically significant. The analyses were performed by Prism software (version 4; GraphPad).
Online supplemental material.
Materials and methods describes the generation and breeding of mDia1-deficient mice and the RT-PCR analysis of WASP mRNA. Fig. S1 shows a diagram of the loxP-frt/Neo cassette used in the targeting vector, schematic representation of the wild-type allele, the targeting vector, the targeted allele and the knockout allele for mDia1, and a PCR genotyping and ratio of wild-type, heterozygous, and homozygous littermates. Fig. S2 shows chemokine responses of mDia1–/– B cells examined by F-actin staining. Fig. S3 shows RT-PCR and real-time PCR of WASP mRNA in mDia1+/+ and mDia1–/– T cells. Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20062647/DC1.
| Acknowledgments |
|---|
This work was supported in part by a Grant-in-Aid for Specially Promoted Research from the Ministry for Education, Culture, Sports, Science and Technology.
The authors have no conflicting financial interests.
Submitted: 19 December 2006
Accepted: 12 July 2007
| REFERENCES |
|---|
|
|
|---|
1 Cyster, J.G. 2005. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23:127–159.[CrossRef][Medline]
2 Ridley, A.J., M.A. Schwartz, K. Burridge, R.A. Firtel, M.H. Ginsberg, G. Borisy, J.T. Parsons, and A.R. Horwitz. 2003. Cell migration: integrating signals from front to back. Science. 302:1704–1709.
3 Faix, J., and R. Grosse. 2006. Staying in shape with formins. Dev. Cell. 10:693–706.[CrossRef][Medline]
4 Higashida, C., T. Miyoshi, A. Fujita, F. Oceguera-Yanez, J. Monypenny, Y. Andou, S. Narumiya, and N. Watanabe. 2004. Actin polymerization-driven molecular movement of mDia1 in living cells. Science. 303:2007–2010.
5 Pollard, T.D., and G.G. Borisy. 2003. Cellular motility driven by assembly and disassembly of actin filaments. Cell. 112:453–465.[CrossRef][Medline]
6 Hall, A. 2005. Rho GTPases and the control of cell behaviour. Biochem. Soc. Trans. 33:891–895.[CrossRef][Medline]
7 Ochs, H.D., and L.D. Notarangelo. 2005. Structure and function of the Wiskott-Aldrich syndrome protein. Curr. Opin. Hematol. 12:284–291.[CrossRef][Medline]
8 Thrasher, A.J. 2002. WASp in immune-system organization and function. Nat. Rev. Immunol. 2:635–646.[CrossRef][Medline]
9 Watanabe, N., P. Madaule, T. Reid, T. Ishizaki, G. Watanabe, A. Kakizuka, Y. Saito, K. Nakao, B.M. Jockusch, and S. Narumiya. 1997. p140 mDia, a mammalian homolog of Drosophila diaphanous, is a target protein for Rho small GTPase and is a ligand for profilin. EMBO J. 16:3044–3056.[CrossRef][Medline]
10 Watanabe, N., T. Kato, A. Fujita, T. Ishizaki, and S. Narumiya. 1999. Cooperation between mDia and ROCK in Rho-induced actin reorganization. Nat. Cell Biol. 1:136–143.[CrossRef][Medline]
11 Hotulainen, P., and P. Lappalainen. 2006. Stress fibers are generated by two distinct actin assembly mechanisms in motile cells. J. Cell Biol. 173:383–394.
12 Lakso, M., J.G. Pichel, J.R. Gorman, B. Sauer, Y. Okamoto, E. Lee, F.W. Alt, and H. Westphal. 1996. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA. 93:5860–5865.
13 Stein, J.V., and C. Nombela-Arrieta. 2005. Chemokine control of lymphocyte trafficking: a general overview. Immunology. 116:1–12.[Medline]
14 Ara, T., M. Itoi, K. Kawabata, T. Egawa, K. Tokoyoda, T. Sugiyama, N. Fujii, T. Amagai, and T. Nagasawa. 2003. A role of CXC chemokine ligand 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell development in vivo. J. Immunol. 170:4649–4655.
15 Miyasaka, M., and T. Tanaka. 2004. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat. Rev. Immunol. 4:360–370.[CrossRef][Medline]
16 Yamana, N., Y. Arakawa, T. Nishino, K. Kurokawa, M. Tanji, J. Monypenny, T. Ishizaki, H. Bito, K. Nozaki, N. Hashimoto, et al. 2006. Rho-mDia1 pathway regulates cell polarity and focal adhesion turnover in migrating cells through mobilizing Apc and c-Src. Mol. Cell. Biol. 26:6844–6858.
17 Zhang, J., A. Shehabeldin, L.A. da Cruz, J. Butler, A.K. Somani, M. McGavin, I. Kozieradzki, A.O. dos Santos, A. Nagy, S. Grinstein, et al. 1999. Antigen receptor–induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein–deficient lymphocytes. J. Exp. Med. 190:1329–1342.
18 Zicha, D., W.E. Allen, P.M. Brickell, C. Kinnon, G.A. Dunn, G.E. Jones, and A.J. Thrasher. 1998. Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br. J. Haematol. 101:659–665.[CrossRef][Medline]
19 Suetsugu, S., M. Hattori, H. Miki, T. Tezuka, T. Yamamoto, K. Mikoshiba, and T. Takenawa. 2002. Sustained activation of N-WASP through phosphorylation is essential for neurite extension. Dev. Cell. 3:645–658.[CrossRef][Medline]
20 Kunda, P., G. Craig, V. Dominguez, and B. Baum. 2003. Abi, Sra1, and Kette control the stability and localization of SCAR/WAVE to regulate the formation of actin-based protrusions. Curr. Biol. 13:1867–1875.[CrossRef][Medline]
21 Tominaga, T., E. Sahai, P. Chardin, F. McCormick, S.A. Courtneidge, and A.S. Alberts. 2000. Diaphanous-related formins bridge Rho GTPase and Src tyrosine kinase signaling. Mol. Cell. 5:13–25.[CrossRef][Medline]
22 Meng, W., M. Numazaki, K. Takeuchi, Y. Uchibori, Y. Ando-Akatsuka, M. Tominaga, and T. Tominaga. 2004. DIP (mDia interacting protein) is a key molecule regulating Rho and Rac in a Src-dependent manner. EMBO J. 23:760–771.[CrossRef][Medline]
23 Fukuoka, M., S. Suetsugu, H. Miki, K. Fukami, T. Endo, and T. Takenawa. 2001. A novel neural Wiskott-Aldrich syndrome protein (N-WASP) binding protein, WISH, induces Arp2/3 complex activation independent of Cdc42. J. Cell Biol. 152:471–482.
24 Kabashima, K., T. Murata, H. Tanaka, T. Matsuoka, D. Sakata, N. Yoshida, K. Katagiri, T. Kinashi, T. Tanaka, M. Miyasaka, et al. 2003. Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat. Immunol. 4:694–701.[CrossRef][Medline]
25 Katagiri, K., N. Ohnishi, K. Kabashima, T. Iyoda, N. Takeda, Y. Shinkai, K. Inaba, and T. Kinashi. 2004. Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking. Nat. Immunol. 5:1045–1051.[CrossRef][Medline]
26 Fukui, Y., O. Hashimoto, T. Sanui, T. Oono, H. Koga, M. Abe, A. Inayoshi, M. Noda, M. Oike, T. Shirai, and T. Sasazuki. 2001. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature. 412:826–831.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|